The costs to treat heart disease and stoke in the United States are expected to triple in the next twenty years according to the American Heart Association.  Read this article from Bloomberg Businessweek to learn more. 

“The burden of heart disease and stroke on the U.S. health care system will be substantial and will limit our ability to care for the U.S. population unless we can take steps now to prevent cardiovascular disease,” said Dr. Paul Heidenreich, an associate professor of medicine at Stanford Medical School and chair of the American Heart Association panel issuing the policy statement.

Click here for full article: